Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Current Opinion in Drug Discovery & Development|August 4, 2009
Tubulin as a target for anticancer drugsE von AngererJournal of Medicinal Chemistry|November 1, 1982
Effect of N,N'-diethyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines on the 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma of the ratE von AngererJournal of Medicinal Chemistry|January 1, 1987
2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activityE von Angerer, J StrohmeierArchiv Der Pharmazie|September 1, 1990
2-phenylindole-linked nitroimidazoles as potential radiosensitizers for estrogen receptor positive tumorsS Erber, E von AngererArchiv Der Pharmazie|October 30, 1998
2-Phenylbenzo[b]thiophene-based antiestrogens with mammary tumor inhibiting activityS Leichtl, E von AngererJournal of Medicinal Chemistry|September 1, 1988
Platinum complexes with binding affinity for the estrogen receptorN Knebel, E von AngererBiochemical Pharmacology|June 1, 1990
Sulfate derivatives of 2-phenylindoles as novel steroid sulfataseinhibitors. An in vitro study on structure-activity-relationshipH Birnböck, E von AngererJournal of Medicinal Chemistry|January 1, 1983
2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compoundsE von Angerer, J PrekajacJournal of Cancer Research and Clinical Oncology|January 1, 1993
Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumoursA Maucher, E von AngererThe Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activityE von Angerer, S ErberPageof 6